A treatment of inhaled inorganic nitrite did not improve exercise capacity among patients with a common form of heart failure, according to a clinical trial published in JAMA.
Two drugs commonly prescribed to treat Type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or amputation, according to a new Northwestern Medicine study.
A drug called brentuximab vedotin combined with chemotherapy significantly improved overall survival for patients with a type of T-cell lymphoma, according to a clinical trial in The Lancet.
A new study aims to answer a resilience puzzle: Why second-hand experiences of neighborhood violence affect some youth, but not others.
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
The world’s smallest wearable device has been developed by Northwestern scientists, to measure exposure to light across multiple wavelengths.
Adults who develop high blood pressure before the age of 40 are at a significantly higher risk for cardiovascular events later in life, according to a Northwestern Medicine study.
Teens and young adults with cancer get support from a special oncology program. Read the story in Northwestern Medicine magazine.
The Lurie Cancer Center solidifies its place among the country’s elite after extraordinary growth and a top rating from the National Cancer Institute. Read the story in Northwestern Medicine magazine.
The more sensitive a person is to the bitter taste of caffeine, the more coffee they tend to drink, according to a new study.
Notifications